NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/12/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization618.07 mln
Float25.34 mln
Earnings Date08/04/2026
Beneish M-Score
-2.53
Likely reliable
1-Year Forecast
19.18
Strong upside
Relative Strength
97
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-22.61
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Beta Bionics makes medical devices that help people with diabetes manage their insulin automatically. Its main product, the iLet Bionic Pancreas, handles insulin delivery on its own for adults and children as young as six who have type 1 diabetes. The company is working on several new products, including a tubeless patch pump, a device that delivers both insulin and glucagon, and a version of iLet designed for type 2 diabetes patients. Founded in 2015 and based in Irvine, California, Beta Bionics works alongside Abbott Diabetes Care and Xeris Pharmaceuticals to bring these solutions to market.
